Skip to main content

Table 3 Latent class estimates (posterior mean and 95% credibility intervals (PCI)) of test Se and Sp and Divisional seroprevalence for the full data set (adults and juveniles) using all three tests and pairs of tests in combination

From: Evaluation of three 3ABC ELISAs for foot-and-mouth disease non-structural antibodies using latent class analysis

 

All three tests

I-ELISA+C-ELISA

I-ELISA+CHEKIT

CHEKIT+C-ELISA

Parameter

Mean

95% PCI

Mean

95% PCI

Mean

95% PCI

mean

95% PCI

SeCHEKIT

33.2

(29.6; 37.0)

-

-

34.2

(28.0; 45.1)

36.0

(29.1; 47.0)

SpCHEKIT

99.0

(98.1; 99.1)

-

-

99.3

(98.0; 100.0)

99.1

(97.7; 100.0)

SeC-ELISA

96.9

(94.0; 99.1)

95.0

(88.2; 99.7)

-

-

96.6

(92.7; 99.8)

SpC-ELISA

90.9

(87.9; 93.8)

94.9

(88.9; 99.7)

-

-

86.4

(72.3; 98.8)

SeI-ELISA

97.1

(94.4; 99.1)

93.3

(88.5; 99.1)

96.4

(92.7; 99.6)

-

-

SpI-ELISA

88.8

(85.8; 92.0)

90.8

(85.6; 97.9)

88.2

(72.3; 99.3)

-

-

pvina

54.1

(49.1; 59.1)

57.4

(51.1; 63.6)

53.5

(41.1; 61.8)

51.7

(39.5; 60.7)

pmbere

46.3

(39.4; 53.3)

50.2

(41.5; 58.5)

44.5

(33.7; 53.5)

47.2

(35.5; 57.1)

pdjerem

30.1

(25.1; 37.0)

34.0

(26.7; 42.1)

30.9

(17.8; 41.8)

25.8

(14.5; 37.0)

pbanyo

50.9

(44.5; 57.2)

54.3

(46.6; 62.5)

52.5

(36.6; 62.8)

44.5

(29.3; 56.2)

pfaro

49.4

(41.4; 57.5)

53.0

(43.5; 61.8)

48.0

(35.2; 58.9)

48.4

(35.7; 59.9)